These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 20022081)

  • 21. The intrinsic pathway of coagulation: a target for treating thromboembolic disease?
    Gailani D; Renné T
    J Thromb Haemost; 2007 Jun; 5(6):1106-12. PubMed ID: 17388803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of a humanized FXII knock-in mouse-A powerful model system to test novel anti-thrombotic agents.
    Beck S; Stegner D; Loroch S; Baig AA; Göb V; Schumbrutzki C; Eilers E; Sickmann A; May F; Nolte MW; Panousis C; Nieswandt B
    J Thromb Haemost; 2021 Nov; 19(11):2835-2840. PubMed ID: 34363738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CpaA Is a Glycan-Specific Adamalysin-like Protease Secreted by Acinetobacter baumannii That Inactivates Coagulation Factor XII.
    Waack U; Warnock M; Yee A; Huttinger Z; Smith S; Kumar A; Deroux A; Ginsburg D; Mobley HLT; Lawrence DA; Sandkvist M
    mBio; 2018 Dec; 9(6):. PubMed ID: 30563903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factor XII in Hemostasis and Thrombosis: Active Player or (Innocent) Bystander?
    Danese E; Montagnana M; Lippi G
    Semin Thromb Hemost; 2016 Sep; 42(6):682-8. PubMed ID: 27074440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cationic zinc is required for factor XII recruitment and activation by stimulated platelets and for thrombus formation in vivo.
    Chaudhry SA; Serrata M; Tomczak L; Higgins S; Ryu J; Laprise D; Enjyoji K; Bekendam R; Kaushik V; Flaumenhaft R; Bendapudi PK
    J Thromb Haemost; 2020 Sep; 18(9):2318-2328. PubMed ID: 32542960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FXII.
    Fuhrer G; Gallimore MJ; Heller W; Hoffmeister HE
    Blut; 1990 Nov; 61(5):258-66. PubMed ID: 2271772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet polyphosphates: the nexus of primary and secondary hemostasis.
    Müller F; Renné T
    Scand J Clin Lab Invest; 2011 Apr; 71(2):82-6. PubMed ID: 21385010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel roles for factor XII-driven plasma contact activation system.
    Müller F; Renné T
    Curr Opin Hematol; 2008 Sep; 15(5):516-21. PubMed ID: 18695377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted deletion of murine coagulation factor XII gene-a model for contact phase activation in vivo.
    Pauer HU; Renné T; Hemmerlein B; Legler T; Fritzlar S; Adham I; Müller-Esterl W; Emons G; Sancken U; Engel W; Burfeind P
    Thromb Haemost; 2004 Sep; 92(3):503-8. PubMed ID: 15351846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo activation and functions of the protease factor XII.
    Björkqvist J; Nickel KF; Stavrou E; Renné T
    Thromb Haemost; 2014 Nov; 112(5):868-75. PubMed ID: 25187064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Model for surface-dependent factor XII activation: the roles of factor XII heavy chain domains.
    Shamanaev A; Ivanov I; Sun MF; Litvak M; Srivastava P; Mohammed BM; Shaban R; Maddur A; Verhamme IM; McCarty OJT; Law RHP; Gailani D
    Blood Adv; 2022 May; 6(10):3142-3154. PubMed ID: 35086137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of the factor XII contact activation site enables sensitive coagulation diagnostics.
    Heestermans M; Naudin C; Mailer RK; Konrath S; Klaetschke K; Jämsä A; Frye M; Deppermann C; Pula G; Kuta P; Friese MA; Gelderblom M; Sickmann A; Preston RJS; Nofer JR; Rose-John S; Butler LM; Salomon O; Stavrou EX; Renné T
    Nat Commun; 2021 Sep; 12(1):5596. PubMed ID: 34552086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrinsic pathway of coagulation and arterial thrombosis.
    Gailani D; Renné T
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2507-13. PubMed ID: 17916770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coagulation factor XII induces pro-inflammatory cytokine responses in macrophages and promotes atherosclerosis in mice.
    Vorlova S; Koch M; Manthey HD; Cochain C; Busch M; Chaudhari SM; Stegner D; Yepes M; Lorenz K; Nolte MW; Nieswandt B; Zernecke A
    Thromb Haemost; 2017 Jan; 117(1):176-187. PubMed ID: 27786338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma levels of bradykinin are suppressed in factor XII-deficient mice.
    Iwaki T; Castellino FJ
    Thromb Haemost; 2006 Jun; 95(6):1003-10. PubMed ID: 16732380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factor XII Osaka: abnormal factor XII with partially defective prekallikrein cleavage activity.
    Iijima K; Arakawa Y; Sugahara Y; Matsushita M; Moriguchi Y; Shimohiro H; Nakagawa M
    Thromb Haemost; 2011 Mar; 105(3):473-8. PubMed ID: 21264442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent advances in factor XII structure and function.
    Shamanaev A; Litvak M; Gailani D
    Curr Opin Hematol; 2022 Sep; 29(5):233-243. PubMed ID: 35916558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An update on factor XII-driven vascular inflammation.
    Mailer RK; Rangaswamy C; Konrath S; Emsley J; Renné T
    Biochim Biophys Acta Mol Cell Res; 2022 Jan; 1869(1):119166. PubMed ID: 34699874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelets promote coagulation factor XII-mediated proteolytic cascade systems in plasma.
    Johne J; Blume C; Benz PM; Pozgajová M; Ullrich M; Schuh K; Nieswandt B; Walter U; Renné T
    Biol Chem; 2006 Feb; 387(2):173-8. PubMed ID: 16497149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factor XII Explored with AlphaFold - Opportunities for Selective Drug Development.
    Frunt R; El Otmani H; Gibril Kaira B; de Maat S; Maas C
    Thromb Haemost; 2023 Feb; 123(2):177-185. PubMed ID: 36167333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.